The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Autoantibody Production in Cancer—The Humoral Immune Response toward Autologous Antigens in Cancer Patients
Open accessAbstract
A link between autoimmune responses and cancer via autoantibodies was first described in the 1950s. Since, autoantibodies have been studied for their potential use as cancer biomarkers, however the exact causes of their production remain to be elucidated. This review summarizes current theories of the causes of autoantibody production in cancer, namely: 1) defects in tolerance and inflammation, 2) changes in protein expression levels, 3) altered protein structure, and 4) cellular death mechanisms. We also highlight the need for further research into this field to improve our understanding of autoantibodies as biomarkers for cancer development and progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738 · cited 1×
“The most common cancer-related changes involve glycosylation [58] and phosphorylation [59], which can affect antigen processing, binding, and interaction of the MHC presented antigen with the TCR, therefore activating the T helper response needed to mount a humoral autoantibody response.”
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
Cancer/testis antigens, gametogenesis and cancer
Simpson, A. J. G., Caballero, O. L., Jungbluth, A., Chen, Y.-T., & Old, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1669 · Cited by 1,582
Death by design: apoptosis, necrosis and autophagy
Edinger, A. L., & Thompson, C. B. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.011 · Cited by 1,364
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Glycosylation defining cancer malignancy: New wine in an old bottle
Hakomori, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172380699 · Cited by 960
Receptor editing: an approach by autoreactive B cells to escape tolerance.
Gay, D., Saunders, T., Camper, S., & Weigert, M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.999 · Cited by 920
The Inflammatory Response to Cell Death
Rock, K. L., & Kono, H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151456 · Cited by 912
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
Scanlan., M. J., Gure., A. O., Jungbluth., A. A., Old., L. J., & Chen., Y. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18803.x · Cited by 873
Improving the efficacy of antibody-based cancer therapies
Carter, P. (2001) · Nature Reviews Cancer · doi:10.1038/35101072 · Cited by 833
Does the Immune System See Tumors as Foreign or Self?
Pardoll, D. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141135 · Cited by 753
Cellular and genetic mechanisms of self tolerance and autoimmunity
Goodnow, C. C., Sprent, J., de St Groth, B. F., & Vinuesa, C. G. (2005) · Nature · doi:10.1038/nature03724 · Cited by 699
Autoantibody Signatures in Prostate Cancer
Wang, X., Yu, J., Sreekumar, A., Varambally, S., Shen, R., Giacherio, D., Mehra, R., Montie, J. E., Pienta, K. J., Sanda, M. G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051931 · Cited by 582
p53 Antibodies in the sera of patients with various types of cancer: a review.
Soussi, T. (2000) · PubMed · Cited by 550
Kamradt, T., & Mitchison, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440907 · Cited by 457
Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer
Joseph, C. G., Darrah, E., Shah, A. A., Skora, A. D., Casciola-Rosen, L. A., Wigley, F. M., Boin, F., Fava, A., Thoburn, C., Kinde, I., et al. (2014) · Science · doi:10.1126/science.1246886 · Cited by 436
Schwitalle, Y., Kloor, M., Eiermann, S., Linnebacher, M., Kienle, P., Knaebel, H. P., Tariverdian, M., Benner, A., & von Knebel Doeberitz, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.015 · Cited by 387
The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
Stamell, E. F., Wolchok, J. D., Gnjatic, S., Lee, N. Y., & Brownell, I. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.03.017 · Cited by 387
Graus, F., Dalmou, J., Reñé, R., Tora, M., Malats, N., Verschuuren, J. J., Cardenal, F., Viñolas, N., Garcia del Muro, J., Vadell, C., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2866 · Cited by 378
Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands
Kaiser, B. K., Yim, D., Chow, I.-T., Gonzalez, S., Dai, Z., Mann, H. H., Strong, R. K., Groh, V., & Spies, T. (2007) · Nature · doi:10.1038/nature05768 · Cited by 377
Inhibition of follicular T-helper cells by CD8+ regulatory T cells is essential for self tolerance
Kim, H.-J., Verbinnen, B., Tang, X., Lu, L., & Cantor, H. (2010) · Nature · doi:10.1038/nature09370 · Cited by 359
The Sentinel Within: Exploiting the Immune System for Cancer Biomarkers
Anderson, K. S., & LaBaer, J. (2005) · Journal of Proteome Research · doi:10.1021/pr0500814 · Cited by 314
Autoantibodies to tumor‐associated antigens: reporters from the immune system
Tan, E. M., & Zhang, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00611.x · Cited by 309
Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2
Agrawal, B., Krantz, M. J., Reddish, M. A., & Longenecker, B. M. (1998) · Nature Medicine · doi:10.1038/nm0198-043 · Cited by 294
Post-translational protein modifications in antigen recognition and autoimmunity
Doyle, H. A., & Mamula, M. J. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01976-7 · Cited by 280
A systematic review of humoral immune responses against tumor antigens
Reuschenbach, M., von Knebel Doeberitz, M., & Wentzensen, N. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-009-0733-4 · Cited by 280
Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis
Ohba, K., Omagari, K., Nakamura, T., Ikuno, N., Saeki, S., Matsuo, I., Kinoshita, H., Masuda, J., Hazama, H., Sakamoto, I., et al. (1998) · Gut · doi:10.1136/gut.43.4.575 · Cited by 277
Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes
Wandall, H. H., Blixt, O., Tarp, M. A., Pedersen, J. W., Bennett, E. P., Mandel, U., Ragupathi, G., Livingston, P. O., Hollingsworth, M. A., Taylor-Papadimitriou, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2893 · Cited by 266
Tarp, M. A., Sørensen, A. L., Mandel, U., Paulsen, H., Burchell, J., Taylor-Papadimitriou, J., & Clausen, H. (2007) · Glycobiology · doi:10.1093/glycob/cwl061 · Cited by 262
Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage
Barrow, C., Browning, J., MacGregor, D., Davis, I. D., Sturrock, S., Jungbluth, A. A., & Cebon, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1544 · Cited by 238
Protein Microarray Signature of Autoantibody Biomarkers for the Early Detection of Breast Cancer
Anderson, K. S., Sibani, S., Wallstrom, G., Qiu, J., Mendoza, E. A., Raphael, J., Hainsworth, E., Montor, W. R., Wong, J., Park, J. G., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr100686b · Cited by 220
Wang, R.-F., Johnston, S. L., Zeng, G., Topalian, S. L., Schwartzentruber, D. J., & Rosenberg, S. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3596 · Cited by 204
Zhang, J.-Y., Chan, E. K. L., Peng, X.-X., & Tan, E. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1101 · Cited by 202
Induction of anti-self-immunity to cure cancer
Nanda, N. K., & Sercarz, E. E. (1995) · Cell · doi:10.1016/0092-8674(95)90047-0 · Cited by 196
B‐Cell Self‐Tolerance in Humans
Wardemann, H., & Nussenzweig, M. C. (2007) · Advances in Immunology · doi:10.1016/s0065-2776(07)95003-8 · Cited by 195
Jinushi, M., Nakazaki, Y., Dougan, M., Carrasco, D. R., Mihm, M., & Dranoff, G. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30966 · Cited by 195
The autoantibody repertoire: searching for order
Plotz, P. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri976 · Cited by 187
Post-translational modifications of self antigens: implications for autoimmunity
Anderton, S. M. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.09.001 · Cited by 170
Jinushi, M., Hodi, F. S., & Dranoff, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603503103 · Cited by 168
Molecular Serum Markers of Liver Fibrosis
Liu, T., Wang, X., Karsdal, M. A., Leeming, D. J., & Genovese, F. (2012) · Biomarker Insights · doi:10.4137/bmi.s10009 · Cited by 166
Dangerous attraction: phagocyte recruitment and danger signals of apoptotic and necrotic cells
Peter, C., Wesselborg, S., i, M. H., & Lauber, K. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0472-1 · Cited by 152
Antibody Immunity to the p53 Oncogenic Protein Is a Prognostic Indicator in Ovarian Cancer
Goodell, V., Salazar, L. G., Urban, N. D., Drescher, C. W., Gray, H. J., Swensen, R. E., McIntosh, M. W., & Disis, M. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2813 · Cited by 149
Oncogenic protein tyrosine kinases
M�nard, S., Casalini, P., Campiglio, M., Pupa, S. M., & Tagliabue, E. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4277-7 · Cited by 137
B‐cell epitope spreading in autoimmunity
James, J. A., & Harley, J. B. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01220.x · Cited by 135
Autoantibody Signature for the Serologic Detection of Ovarian Cancer
Anderson, K. S., Cramer, D. W., Sibani, S., Wallstrom, G. L., Wong, J., Park, J. K., Qiu, J., Vitonis, A. F., & LaBaer, J. (2014) · Journal of Proteome Research · doi:10.1021/pr500908n · Cited by 116
Yonezawa, S., Goto, M., Yamada, N., Higashi, M., & Nomoto, M. (2008) · PROTEOMICS · doi:10.1002/pmic.200800040 · Cited by 115
p53 Autoantibodies as Potential Detection and Prognostic Biomarkers in Serous Ovarian Cancer
Anderson, K. S., Wong, J., Vitonis, A. F., Crum, C. P., Sluss, P. M., LaBaer, J., & Cramer, D. W. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0880 · Cited by 109
Bei, R., Masuelli, L., Palumbo, C., Modesti, M., & Modesti, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.11.009 · Cited by 106
Zhang, J.-Y., & Tan, E. M. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.12 · Cited by 91
Linnebacher, M., & Maletzki, C. (2012) · OncoImmunology · doi:10.4161/onci.20641 · Cited by 68
Silencing of autoreactive B cells by anergy: a fresh perspective
Gauld, S. B., Merrell, K. T., & Cambier, J. C. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.015 · Cited by 57
Autoantibodies as Biomarkers in Cancer
Pedersen, J. W., & Wandall, H. H. (2011) · Laboratory Medicine · doi:10.1309/lm2t3ou3rzrthksn · Cited by 56
Good riddance: thymocyte clonal deletion prevents autoimmunity
Venanzi, E. S., Benoist, C. O., & Mathis, D. J. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.01.008 · Cited by 56
Burford, B., Gentry‐Maharaj, A., Graham, R. A., Allen, D., Pedersen, J. W., Nudelman, A. S., Blixt, O., Fourkala, E.-O., Bueti, D., Dawnay, A., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.214 · Cited by 55
Arias, D. A. A., Kim, H. J., Zhou, P., Holderried, T. A. W., Wang, X., Dranoff, G., & Cantor, H. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0121 · Cited by 54
Antinuclear autoantibodies as potential antineoplastic agents
Torchilin, V. P., Iakoubov, L. Z., & Estrov, Z. E. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01984-6 · Cited by 48
Carl, P. L., Temple, B. R. S., & Cohen, P. L. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1832 · Cited by 41
Germinal center checkpoints in B cell tolerance in 3H9 transgenic mice
Paul, E. (2004) · International Immunology · doi:10.1093/intimm/dxh035 · Cited by 32
The Impact of Autoimmune Diseases on the Incidence and Prognosis of Cutaneous Malignant Melanoma
Kaae, J., Wohlfahrt, J., Boyd, H. A., Wulf, H. C., Biggar, R. J., & Melbye, M. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0459 · Cited by 18
Regulation of autoreactive B cells: checkpoints and activation
Ding, C., & Yan, J. (2007) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-007-0011-0 · Cited by 17
Patient knowledge about prostate‐specific antigen (PSA) and prostate cancer in Australia
Pan, D., & McCahy, P. J. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11048.x · Cited by 8
Cited by
Progress and prospects of early detection in lung cancer
Blandin Knight, S., Crosbie, P. A., Balata, H., Chudziak, J., Hussell, T., & Dive, C. (2017) · Open Biology · doi:10.1098/rsob.170070 · Cited by 935
de Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D., Gill, S., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 535
Xing, M., Li, P., Wang, X., Li, J., Shi, J., Qin, J., Zhang, X., Ma, Y., Francia, G., & Zhang, J.-Y. (2019) · Cancers · doi:10.3390/cancers12010007 · Cited by 39
Metadata
- Authors
- Zaenker, P., Gray, E. S., & Ziman, M. R.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 15
- Issue
- 5
- Pages
- 477-483
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W2295114890
- Cited by
- 267
- References
- 67
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.